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Abstract
Following	injury,	skin	activates	a	complex	wound	healing	programme.	While	cellular	
and	signalling	mechanisms	of	wound	repair	have	been	extensively	studied,	the	prin-
ciples	of	epidermal-	dermal	interactions	and	their	effects	on	wound	healing	outcomes	
are	 only	 partially	 understood.	 To	 gain	 new	 insight	 into	 the	 effects	 of	 epidermal-	
dermal	interactions,	we	developed	a	multiscale,	hybrid	mathematical	model	of	skin	
wound	healing.	The	model	takes	into	consideration	interactions	between	epidermis	
and	dermis	across	the	basement	membrane	via	diffusible	signals,	defined	as	activator	
and	inhibitor.	Simulations	revealed	that	epidermal-	dermal	interactions	are	critical	for	
proper	extracellular	matrix	deposition	 in	 the	dermis,	 suggesting	 these	 signals	may	
influence	how	wound	scars	form.	Our	model	makes	several	theoretical	predictions.	
First,	basal	 levels	of	epidermal	activator	and	 inhibitor	help	to	maintain	dermis	 in	a	
steady	state,	whereas	their	absence	results	in	a	raised,	scar-	like	dermal	phenotype.	
Second,	wound-	triggered	increase	in	activator	and	inhibitor	production	by	basal	epi-
dermal	cells,	coupled	with	fast	re-	epithelialization	kinetics,	reduces	dermal	scar	size.	
Third,	high-	density	fibrin	clot	leads	to	a	raised,	hypertrophic	scar	phenotype,	whereas	
low-	density	fibrin	clot	 leads	to	a	hypotrophic	phenotype.	Fourth,	shallow	wounds,	
compared	 to	deep	wounds,	 result	 in	overall	 reduced	 scarring.	Taken	 together,	our	
model	predicts	the	important	role	of	signalling	across	dermal-	epidermal	interface	and	
the	effect	of	fibrin	clot	density	and	wound	geometry	on	scar	formation.	This	hybrid	
modelling	approach	may	be	also	applicable	to	other	complex	tissue	systems,	enabling	
the	 simulation	 of	 dynamic	 processes,	 otherwise	 computationally	 prohibitive	 with	
fully	discrete	models	due	to	a	large	number	of	variables.
K E Y W O R D S
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1  | INTRODUC TION
Skin	 functions	 as	 a	 vital	 interface	 between	 organism	 and	 its	 en-
vironment.	 When	 injured,	 skin	 rapidly	 heals	 via	 a	 wound	 healing	
programme	 characterized	 by	 four	 distinct	 yet	 overlapping	 phases:	
hemostasis,	inflammation,	proliferation	and	remodelling1,2.	The	pri-
mary	goal	of	 this	 repair	programme	 is	 to	 re-	establish	barrier	 func-
tion	 by	 reforming	 stratified	 epidermis	 and	 restoring	 dermal	 tissue	
integrity3,4.	During	the	remodelling	phase,	regeneration	of	new	hair	
follicles5–8	and	adipose	tissue9,10	can	also	take	place.	Cellular	or	mo-
lecular	defects	during	any	of	these	phases	can	lead	to	pathological	
wound	healing	outcomes.
Molecular	 composition	 and	 high-	order	 structure	 of	 collagen	
bundles	 laid	 by	wound	 fibroblasts	 determine	 the	 architecture	 and	
the	 “quality”	 of	 the	 dermal	 scar,	 and	 collagen	deposition	 is	 tightly	
regulated	 by	 paracrine,	 autocrine	 and	mechanical	 signals11.	While	
collagen	architecture	of	normal	skin	is	intricate	and	weave-	like,	scars	
typically	have	“less	desirable”	highly	parallel	collagen12,13.	Epidermal	
keratinocytes	can	signal	to	dermal	fibroblasts	to	decrease	collagen	
production14,	 while	 direct	 contact	 between	 two	 cell	 types	 stim-
ulates	 keratinocyte	 proliferation	 and	 migration	 during	 wound	 re-	
epithelialization15.	Epidermal-	dermal	 crosstalk	occurs	via	 signalling	
growth	factors16,	and,	for	example,	both	wound	keratinocytes	and	
fibroblasts	secrete	transforming	growth	factor	beta	(TGFβ)	ligands,	
the	key	wound	healing	mediators17–19.	TGFβ1	is	also	abundant	in	the	
platelet-	rich	fibrin	clot	and	has	been	linked	to	excessive	extracellular	
matrix	 (ECM)	deposition20.	This	suggests	 that	 together	with	kerat-
inocytes,	 fibroblasts	and	 immune	cells,	 fibrin	clot	serves	as	an	 im-
portant	signalling	centre	during	wound	repair.	While	multiple	 lines	
of	 evidence	 point	 towards	 the	 importance	 of	 signalling	 crosstalk	
between	key	cellular	and	molecular	components	of	the	wound,	the	
overall	logic	of	these	interactions	during	scar	formation	remains	in-
completely	understood.
Mathematical	modelling	offers	a	useful	approach	to	study	prin-
ciples	of	wound	healing.	 In	 the	past,	 reaction-	diffusion	model	has	
been	 implemented	 to	 study	biochemical	 regulation	of	 cell	 cycle	 in	
the	 epidermis	 during	 wound	 re-	epithelialization21.	 Another	 study	
implemented	 hybrid	model	 to	 study	 how	 collagen	 fibres	 organize	
during	 wound	 healing	 and	 their	 role	 in	 scarring22,23.	 The	 Cellular	
Potts	model	also	has	been	used	to	investigate	sprouting	and	branch-
ing	during	angiogenesis24	and,	more	recently,	to	examine	prolifera-
tion	and	migration	of	skin	wound	fibroblasts25.
While	 the	 crosstalk	 between	 keratinocytes	 and	 fibroblasts	 via	
soluble	signalling	factors	has	been	previously	analysed	using	a	con-
tinuum model26,	epidermal	and	dermal	compartments	were	treated	
as	one	spatially	homogeneous	region,	without	taking	into	consider-
ation	their	 interactions	and	other	 important	anatomical	aspects	of	
the	skin.	A	finite	element	method	also	has	been	used	to	study	inter-
actions	 between	 keratinocytes,	 fibroblasts	 and	 endothelial	 cells27. 
Although	important,	this	method	did	not	account	for	the	interface	
between	epidermis	and	dermis	and,	instead,	modelled	both	of	these	
distinct	skin	compartments	as	a	continuum.	Unlike	dermis,	epidermis	
consists	only	of	a	few	layers	of	densely	packed	cells,	and	its	discrete	
nature	likely	introduces	important	biological	effects	that	cannot	be	
captured	by	a	continuum	model.
To	simulate	interactions	between	individual	cells	within	spatially	
distinct	epidermis	and	dermis	and	their	effects	on	scarring,	we	de-
veloped	an	optimized	two-	dimensional,	multiscale	hybrid	model	of	
wound	 healing.	 This	 model	 incorporates	 dynamically	 continuous	
epidermal-	dermal	interface,	and	allows	studying	individual	prolifer-
ating	 and	migrating	 keratinocytes	using	discrete	 single-	cell	model,	
and	dermal	fibroblast	functions	using	continuum	model.	Our	simu-
lations	predict	that	both	dermal	and	epidermal	signalling	factors	are	
necessary	to	sustain	steady-	state	ECM	levels	in	normal	skin,	and	to	
regulate	new	ECM	deposition	after	wounding.	Our	model	also	pre-
dicts	that	high-	density	fibrin	clot,	serving	as	the	source	for	signalling	
factors,	can	induce	formation	of	raised	hypertrophic	scars,	whereas	
low-	density	 fibrin	 clot	 has	 the	 opposite	 effect.	 Finally,	 the	model	
predicts	causal	relationships	between	initial	wound	width	and	depth	
and	scarring	outcomes.
2  | METHODS
The	two-	dimensional,	multiscale	hybrid	mathematical	model	con-
sists	of	 two	submodels	allocated	on	 two	separate	homogeneous	
regions:	 the	 dermal	 (D)	 and	 epidermal	 (E)	 regions.	 Each	 region	
is	 distinct	 and	was	modelled	with	 a	 dynamic	 interface	 between	
them,	termed	Ω.	Epidermal	cells	in	E were modelled individually to 
evaluate	their	signal	production	and	proliferation	and	migration	abil-
ities.	 In	contrast,	dermal	 fibroblasts,	 immune	cells,	ECM	 (including	
collagen	bundles),	and	signals	produced	by	cell	 types	not	explicitly	
accounted	for	(such	as	vascular	cells)	were	modelled	in	a	continuum.
2.1 | Discrete model on epidermal cell dynamics 
using subcellular element method
Epidermal	 keratinocytes	were	modelled	 individually	 through	 a	 lin-
ear	 cell	 lineage	composed	of	basal,	 spinous	and	granular	 layer	 ke-
ratinocytes.	Following	our	previous	work28,	a	selective	differential	
cell	adhesion	mechanism	was	implemented	to	allow	for	proper	layer	
stratification.	Individual	cells	and	their	divisions	were	modelled	by	a	
subcellular	element	method29	that	has	been	adapted	to	specifically	
study	epidermis30	(see	Appendix	S1).
2.2 | Continuum model on signalling and 
dermal components
Extracellular	 matrix	 deposition	 and	 diffusive	 signalling	 molecules	
in	both	dermis	and	epidermis	were	modelled	by	reaction-	diffusion	
differential	 equations.	 Dermal	 fibroblasts	 and	 immune	 cells	 were	
modelled	 using	 the	Keller-	Segel	model31,	which	 includes	 reaction-	
diffusion-	advection	equations	controlling	their	diffusion,	chemotac-
tic	movement,	self-	renewal	and	decay.
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2.3 | Coupling of discrete and continuum models 
with dynamic interface
We	modelled	epidermal	basement	membrane	as	a	dynamic	interface	
(Ω)	 to	separate	 the	dermis	and	epidermis	and	used	 the	movement	
of	 such	 interface	 to	mimic	dermal	 scar	 formation	dynamics	during	
wound	 healing.	 The	 dynamic	 nature	 of	 the	 interface	 is	 implicitly	
modelled	by	the	level	set	method32	(see	Appendix	S1).
3  | RESULTS
3.1 | A multiscale model with a dynamic interface 
and epidermal- dermal interactions
We	constructed	a	two-	dimensional,	multiscale	mathematical	model	
composed	 of	 a	 hybrid	 epidermal-	dermal	 interface	 to	 explore	 the	
mechanisms	that	regulate	aspects	of	skin	physiology	during	homeo-
stasis	and	after	wounding.	Epidermis	 (E)	was	modelled	 individually	
with	discrete	keratinocytes,	whereas	dermis	 (D)	was	modelled	 in	a	
continuum	 and	 considers	 diffusive	 signals	 produced	 by	 keratino-
cytes,	 dermal	 fibroblasts,	 immune	 cells	 and	 other	 skin	 cells	 not	
explicitly	 accounted	 for	 (see	Methods).	 Both	 compartments	 were	
modelled	 independently	 and	 separated	 by	 a	 dynamic	 interface,	
termed Ω	 .	During	wound	healing,	ECM	production	and	 fibroblast	
proliferation	 are	 known	 to	be	 regulated	by	multiple	 signalling	 fac-
tors33–37.	Key	signalling	factors	involved	in	wound	healing	are	mem-
bers	of	the	TGF	pathway,	although	their	effects	are	complex.	While	
TGFβ1	promotes	collagen	synthesis33,38,	TGFβ3	shows	downregulat-
ing	effects34,39.	Both	fibroblasts	and	keratinocytes	secrete	TGFβ135,	
and	fibroblasts	 respond	to	TGFβ1	by	proliferating36.	This	suggests	
that	TGFβ1	serves	an	activator	for	fibroblast	proliferation	and	ECM	
production,	whereas	TGFβ3	works	as	an	 inhibitor	of	ECM	produc-
tion.	Signalling	factors	belonging	to	canonical	WNT40–43	and	PDGF	
pathways37,44–46	also	regulate	fibroblast	activity	and	can	serve	the	
role	of	activators	and	inhibitors	in	the	model.
To	 systematically	 study	 the	 role	 of	 putative	 regulatory	 signals	
during	 scar	 formation,	 we	 modelled	 diffusive	 signals	 as	 activator	
(A)	and	 inhibitor	 (I).	A	and	 I	 assume	specific	 roles	 in	our	model—A	
promotes	 fibroblast	 proliferation	 and	 ECM	 production,	 whereas	
I	 inhibits	 ECM	 production.	 The	 model	 obeys	 three	 basic	 condi-
tions	 (Figure	1).	First,	both	basal	epidermal	keratinocytes	and	der-
mal	fibroblasts	produce	A	and	I.	 Immune	cells	can	also	produce	A.	
Second,	A	 and	 I	 diffuse	 through	 the	 dermis,	 and	 their	 production	
rates	are	directly	regulated	by	fibroblast	density	and	ECM	produc-
tion.	Production	of	A	by	immune	cells	is	regulated	by	their	activation	
state,	which	they	enter	when	 local	A	signalling	 levels	are	high	and	
above	a	set	threshold.	Third,	A	positively	regulates	ECM	production,	
while	I	does	the	opposite.	These	processes	are	modelled	in	a	contin-
uum	and	assume	the	following	sets	of	partial	differential	equations:
where	F and C	represent	fibroblast	proliferation/density	and	overall	
ECM	concentration	(measured	as	a	direct	readout	of	collagen	bundle	
production/deposition),	 respectively;	p1 and p2	 represent	 the	con-
centrations	of	I	and	A,	respectively.	The	term	Epi	represents	the	pro-
duction	rate	of	pi	(where	i	=	1,2	in	epidermal	basal	keratinocytes,	and	
IM	represents	immune	cells,	which	also	serves	as	a	source	of	A	(see	
Appendix	S1).	M	 represents	 fibrin	clot,	which	 forms	during	wound	
healing	(see	Appendix	S1).
The	dynamic	interface	between	E and D	was	implicitly	modelled	
by	the	level	set	method	and	implemented	by	the	phase	function	ϕ,	
which	was	determined	by	the	velocity	field	ν.	The	change	in	phase	
function	ϕ	was	defined	by:
(1)
휕F
휕t
=∇(DF∇F−휈FF∇p1)+ fF(F,p2)−dFF
(2)
휕C
휕t
=DCΔC+ fc(F,p1,p2)−dCC
(3)
휕p1
휕t
=Dp1Δp1+ fp1 (F,C,p1)+Ep1 +CMp1M−dp1p1
(4)
휕p2
휕t
=Dp2Δp2+ fp2 (F,C,p2)+Ep2 +CMp2M+ fIM(IM,p2)−dp2p2
(5)
휕휙
휕t
=−v ⋅∇휙
F IGURE  1 Schematic	of	two-	dimensional	multiscale	hybrid	
model	of	wound	healing.	The	modelling	domain	is	separated	
into	epidermis	(E)	(light	blue)	and	dermis	(D)	(grey)	by	a	dynamic	
interface	(Ω)	to	mimic	the	basement	membrane.	In	E,	keratinocytes	
are	modelled	discretely	as	basal	(yellow),	spinous	(light	brown)	and	
granular	(dark	brown)	cells.	Basal	cells	are	set	to	produce	activators	
A	(shaded	green	box)	and	inhibitors	I	(shaded	dark	pink	box)	(rule	
(1)).	In	D,	fibroblasts,	ECM	(shaded	blue	oval)	and	immune	cells	(IM,	
purple)	are	modelled	in	a	continuum,	where	fibroblasts	produce	
A	and	I,	immune	cells	produce	A,	and	these	processes	are	directly	
activated	by	ECM	(rule	(2)).	Additionally,	fibroblast	proliferation	is	
activated	by	A,	production	of	A	by	immune	cells	is	activated	by	A,	
and	ECM	production	is	activated	by	A	and	inhibited	by	I	(rule	(3)).	A	
and	I	exist	in	both	D and E	and	can	diffuse	across	Ω
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FIGURE 2 Dermal	homeostasis	in	normal	skin	depends	on	epidermal	and	dermal	signalling.	(A-	A’’’)	Simulated	ECM	and	fibroblast	densities	
in	unwounded	skin	with	A	and	I	produced	both	by	keratinocytes	and	by	fibroblasts.	Black	line	denotes	the	position	of	basement	membrane	
relative	to	the	simulated	skin	surface.	Fibroblast	density,	and	I	and	A	levels	are	shown	in	(A’),	(A’’)	and	(A’’’),	respectively.	(B)	Simulated	ECM	
and	fibroblast	densities	in	the	model	where	only	fibroblasts	produce	A	and	I.	Significantly	decreased	fibroblast	density,	and	inhibitor	and	
activator	levels	are	shown	in	(B’),	(B’’)	and	(B’’’),	respectively.	(C)	Simulated	ECM	and	fibroblast	densities	in	the	model	where	fibroblasts	
produce	10%	more	I	relative	to	the	homeostatic	condition	(high	I).	Corresponding	fibroblast	density,	and	inhibitor	and	activator	levels	are	
shown	in	(C’),	(C’’)	and	(C’’’),	respectively.	(D)	Simulated	ECM	and	fibroblast	densities	in	the	model	where	fibroblasts	produce	10%	more	A	
relative	to	the	homeostatic	condition	(high	A).	Corresponding	fibroblast	density,	and	inhibitor	and	activator	levels	are	shown	in	(D’),	(D’’)	and	
(D’’’),	respectively.	(E)	Temporal	change	in	average	ECM	density	across	modelling	time.	(F)	Temporal	change	in	average	fibroblast	density	
across	modelling	time.	(G)	Temporal	change	in	dermal	thickness,	as	measured	by	the	position	of	basement	membrane	relative	to	the	skin	
surface,	across	modelling	time.	Colour	definitions	for	each	line	on	E-	G	are	provided	on	the	figure.	Values	along	X-	axis	are	in	simulated	days,	
and	values	along	Y-	axis	are	in	arbitrary	units	(a.u.)
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where	ϕ	 is	 the	 phase	 function	 representing	 the	 epidermal	 region	
(ϕ	>	0)	 and	 dermal	 region	 (ϕ	<	0).	 The	 initial	 condition	 for	ϕ	 is	 the	
signed	 distance	 between	 the	 grid	 point	 and	 the	 interface	 (see	
Appendix	S1).	The	velocity	field	ν	is	encoded	by:
where	C0	(x, y, t)	is	zero	when	(x,y)	is	in	D,	and	C0	(x,y,t)	is	Cstable	≠	0	
when	(x,y)	is	in	E. Cstable	is	ECM	density	in	the	dermis	under	homeo-
static	conditions.	The	interface	will	rise	up	if	C>Cstable	is	satisfied	near	
the	interface	and	decrease	if	C>Cstable	is	satisfied.
3.2 | Coupled signalling between basal 
keratinocytes and fibroblasts maintains dermal 
homeostasis in the model
To	examine	the	effects	of	epidermally	derived	A	and	I	on	dermis	sta-
bility,	we	varied	the	parameters	regulating	signal	production	by	basal	
keratinocytes.	 Initially,	 A	 and	 I	 were	modelled	 such	 that	 they	 are	
found	at	near-	constant	levels	throughout	D	and	in	basal	layer	of	E. 
(Figure	2A”,	A’’’).	Simulations	suggest	that	if	both	basal	keratinocytes	
and	fibroblasts	produce	A	and	I	at	relatively	high	levels	and	immune	
cells	do	not	produce	extra	A	because	of	the	combined	keratinocyte-	
and	fibroblast-	derived	A	levels	are	below	the	threshold	required	for	
immune	cell	activation	(see	Appendix	S1),	ECM	and	fibroblast	densi-
ties	 (which	serve	as	proxies	for	dermal	stability)	are	uniformly	dis-
tributed	across	D	 (Figure	2A,	A’),	but	form	an	upward	gradient	in	E 
(Figure	S1A–A’’’).	The	average	ECM	and	fibroblast	densities,	as	well	
as	A	and	I	levels,	remained	stable	and	did	not	fluctuate	over	a	simu-
lated	 timescale	 of	 6	days	 (Figure	2E,	 F,	 black	 line).	We	used	 these	
simulation	 parameters	 as	 a	 baseline	 to	 represent	 the	 homeostatic	
condition	 in	 the	 following	 simulations,	 where	 A	 and	 I	 production	
rates	and	sources	were	perturbed.
Next,	 we	 tested	 the	 effect	 of	 disabled	 epidermal	 A	 and	 I	 on	
dermal	 homeostasis	 (Figure	2B’’,	 B’’’).	 This	 change	 led	 to	 near-	
constant	 levels	of	ECM	and	 fibroblast	densities	 in	D,	except	near	
the	epidermal-	dermal	interface	(Figure	2B,	B’),	where	A	and	I	gra-
dients	 shifted	 downwards	 into	D	 (Figure	 S1B–B’’’)	 and	 over	 time	
fibroblast	density	decreased	(Figure	2F,	blue	line),	while	ECM	den-
sity	 increased	 (Figure	2E,	blue	 line).	This	 suggests	 that	 epidermal	
activator	 signals	 are	 primarily	 involved	 in	 promoting	 fibroblast	
self-	renewal,	 while	 epidermal	 inhibitor	 signals	 prevent	 exces-
sive	 ECM	 synthesis	 within	 the	 immediate	 basement	 membrane	
(6)v=−K∇(C−C0)
F IGURE  3 Healing	outcomes	of	abrasion	wounds	depend	on	re-	epithelialization	kinetics	and	epidermal	signal	production	rate.	Abrasion	
wound	healing	simulations	were	performed	using	fast	(A-	D’’’)	and	slow	re-	epithelialization	kinetics	(E-	H’’’).	For	each	set	of	re-	epithelialization	
kinetics,	simulations	were	ran	using	“basal”	(C-	D’’’,	G-	H’’’)	and	“high”	epidermal	A/I	production	rates	(A-	B’’’,	E-	F’’’).	For	each	simulated	
condition,	ECM	density	(blue),	fibroblast	density	(pink),	inhibitor	level	(red)	and	activator	level	(green)	are	shown.	For	each	simulation,	
two	consecutive	snapshots	are	shown:	day	2	and	6	for	fast	re-	epithelialization	simulations	and	day	4	and	10	for	slow	re-	epithelialization	
simulations.	Black	line	on	each	image	marks	the	position	of	basement	membrane.	(I)	Temporal	changes	in	average	ECM	density	across	
modelling	time.	(J)	Temporal	changes	in	average	fibroblast	density	across	modelling	time.	(K)	Temporal	changes	in	dermal	scar	thickness	
across	modelling	time.	Colour	definitions	for	each	line	on	I-	K	are	provided	on	the	figure.	Values	along	X-	axis	are	in	simulated	days,	and	values	
along	Y-	axis	are	in	arbitrary	units	(a.u.)
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microenvironment.	Increase	in	ECM	output	under	these	signalling	
perturbations	 led	 to	 dermal	 thickening	 despite	 modest	 decrease	
in	 fibroblast	 density	 (Figure	2G,	 blue	 line).	 This	 is	 because	 in	 the	
model	 ECM	 contributes	 to	 dermal	 volume	 changes	 substantially	
more	 as	 compared	 to	 fibroblasts.	 This	 assumption	 is	 in	 line	with	
the	observations	 that	ECM	occupies	 larger	proportion	of	 a	given	
dermal	 volume	 in	 adult	mouse	 skin	 as	 compared	 to	 fibroblasts25. 
These	results	also	suggest	 that	epidermal	signals	 (primarily	 I)	can	
supplement	 dermal	 signals	 and	 contribute	 to	maintaining	 dermal	
skin	compartment	in	homeostasis.
Next,	we	modelled	 the	 effects	 of	 perturbed	 dermal	 signalling.	
We	varied	the	production	rate	of	A	or	I	in	fibroblasts	to	two	oppo-
site	extremes	and	simulated	changes	in	ECM,	fibroblast	density	and	
dermal	thickness	as	measures	of	dermal	stability.	Simulation	results	
suggest	that	when	the	production	rate	of	I	in	fibroblasts	is	increased	
by	more	than	10%	in	the	upper	D	compartment	(Figure	2C’’),	fibro-
blast	density	modestly	decreased	and	ECM	production	significantly	
decreased	(Figure	2C,	C’),	and	continued	to	decrease	over	the	entire	
simulation	period	(Figure	2E,	F,	red	lines).	As	expected,	these	changes	
resulted	 in	continuously	reducing	dermal	thickness	 (Figure	2G,	red	
line).	On	the	other	hand,	when	the	production	rate	of	A	in	fibroblasts	
is	increased	by	more	than	10%	(Figure	2D’’’),	densities	of	ECM	and	
fibroblasts	 as	well	 as	 dermal	 thickness	 increased	 (Figure	2D,	 2D’),	
and	these	changes	continued	over	the	simulated	time	(Figure	2E–G,	
green	lines).	Together,	these	modelling	results	suggest	that	both	epi-
dermal	and	dermal	sources	for	A	and	I	signals	and	their	balance	are	
likely	necessary	for	dermal	homeostasis.
3.3 | Increased signalling and fast re- 
epithelialization kinetics are essential for scar- free 
healing in simulated epidermal abrasion wounds
Next,	we	asked	how	A	and	I	signals	may	regulate	dermal	repair	dur-
ing	wound	healing.	First,	we	modelled	healing	of	epidermal	abrasion	
wounds.	Epidermal	abrasions	mainly	heal	by	re-	epithelialization,	and	
no	dermal	scar	typically	forms47.	We	carried	out	several	simulations	
in	which	basal	and	suprabasal	keratinocytes	are	stripped,	while	der-
mal	fibroblasts	and	ECM	remain	intact	(Figure	S2A,	B;	see	Appendix	
S1	for	modelling	details).	We	modelled	two	parameter	kinetics	that	
allow	for	 “fast”	and	“slow”	re-	epithelialization	 in	order	 to	simulate	
kinetics	 of	 normal	 and	 delayed	 wound	 healing,	 respectively,	 and	
evaluated	their	effects	on	dermal	homeostasis	during	and	after	re-	
epithelialization	 (Figure	3).	 Both	 re-	epithelialization	 kinetics	 were	
modelled	under	“basal”	(ie	unchanged)	and	“high”	(ie	increased)	epi-
dermal	A/I	production	rates	(Figure	S3;	see	Appendix	S1).	We	also	
assumed	that	immediately	after	epidermal	abrasion,	A/I	levels	in	the	
wound	area	drop	below	normal	levels	due	to	loss	of	keratinocytes,	
which	function	as	the	source	for	signals	(Figure	S2C,	D).
F IGURE  4 Healing	outcomes	of	dermal	wounds	depend	on	wound	geometry	and	fibrin	clot	density.	All	dermal	wound	healing	simulations	
shown	on	this	figure	were	performed	using	high-	density	fibrin	clot	condition.	See	Figure	S10	for	low-	density	fibrin	clot	condition.	The	
following	wound	geometries	were	compared:	(A-	B’’’)	deep	and	wide	wounds,	(C-	D’’’)	shallow	and	wide	wounds,	(E-	F’’’)	very	shallow	and	wide	
wounds,	and	(G-	H’’’)	narrow	and	deep	wounds.	For	each	simulated	condition,	ECM	density	(blue),	fibroblast	density	(pink),	inhibitor	level	(red)	
and	activator	level	(green)	are	shown.	For	each	simulation,	two	consecutive	snapshots	are	shown:	day	2	and	6.	Black	line	on	each	image	marks	
the	position	of	basement	membrane.	(I)	Temporal	changes	in	average	ECM	density	across	modelling	time.	(J)	Temporal	changes	in	average	
fibroblast	density	across	modelling	time.	(K)	Temporal	changes	in	dermal	scar	thickness	across	modelling	time.	(L)	Degradation	dynamics	of	the	
fibrin	clot	across	modelling	time.	Colour	definitions	for	each	line	on	I-	L	are	provided	on	the	figure.	Values	along	X-	axis	are	in	simulated	days,	
and	values	along	Y-	axis	are	in	arbitrary	units	(a.u.)
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First,	 we	 simulated	 the	 effects	 of	 unchanged	 vs	 increased	
A/I	 epidermal	 signalling	 under	 fast	 re-	epithelialization	 kinetics	
(Figure	3A–D’’’).	 Under	 basal	 signalling	 conditions,	 A/I	 levels	 were	
normal	at	 the	wound	edges	but	dropped	directly	beneath	 the	epi-
dermal	wound	 (Figure	3C’’,	C’’’).	Under	 these	 simulated	conditions,	
wound	re-	epithelialization	was	accompanied	by	an	increase	in	dermal	
thickness	(Figure	3K,	blue	line),	an	outcome	that	is	unusual	for	epi-
dermal	abrasions.	This	is	underlined	by	an	increased	ECM	deposition	
(Figure	3D	and	3I,	blue	line),	which	is	the	consequence	of	sustained	
lower	I	levels.	Density	of	fibroblasts	experienced	a	modest	reduction	
(Figure	3J,	blue	 line),	opposite	 to	ECM	changes.	This	 is	also	an	un-
usual	outcome,	and	it	is	driven	by	the	disproportionally	higher	sen-
sitivity	of	ECM	production	to	I	vs	A.	In	contrast,	when	epidermal	A/I	
levels	were	allowed	to	increase	after	abrasion	injury	(Figure	3A’’,	A’’’),	
dermal	 thickness	 of	 re-	epithelialized	 wounds	 did	 not	 significantly	
change	 compared	 to	 homeostatic	 pre-	wounding	 state	 (Figure	3K,	
black	 line)—a	 more	 biologically	 realistic	 outcome.	 Underlying	 this	
dermal	 compartment	behaviour	 in	 the	model	were	near-	normal	 fi-
broblast	 density	 (Figure	3J,	 black	 line)	 and	ECM	density	 (Figure	3I,	
black	line).	These	modelling	results	suggest	that	rapid	increase	in	A/I	
production	by	the	wound	edge	keratinocytes	 is	 likely	necessary	to	
compensate	for	the	loss	of	normal	A/I	levels	due	to	epidermal	injury	
and	for	eventual	scar-	free	healing	of	epidermal	abrasions.
Next,	we	modelled	healing	of	epidermal	abrasion	wounds	under	the	
conditions	of	slow	re-	epithelialization	kinetics,	designed	to	simulate	
chronic	wound	healing	(see	Appendix	S1).	When	modelling	combined	
slow	re-	epithelialization	with	basal	A/I	production	levels	(Figure	3G–
H’’’),	 post-	injury	 ECM	 deposition	 (Figure	3I,	 green	 line)	 and	 dermal	
scarring	 became	 exacerbated	 (Figure	3K,	 green	 line).	 Interestingly,	
when	 modelling	 combined	 slow	 re-	epithelialization	 with	 increased	
rate	of	A/I	production	(Figure	3E-	F’’’),	delayed	re-	epithelialization	ki-
netics	triggered	basal	keratinocytes	into	a	state	of	sustained	elevated	
production	of	A	(Figure	3E’’’)	and	I	(Figure	3E’’).	 In	turn,	such	chron-
ically	high	A/I	levels	resulted	in	dermis	in	and	around	the	wound	area	
to	overproduce	fibroblasts	and	decrease	ECM	(Figure	3I	and	3J,	red	
lines),	causing	modest,	albeit	abnormal	decrease	in	dermal	thickness	
over	simulated	time	(Figure	3K,	red	line).	Dichotomous	behaviour	of	
fibroblasts	and	ECM	in	this	simulation	is	driven	by	higher	sensitivity	
to	changes	 in	A	and	 I,	 respectively.	Taken	 together,	our	simulations	
indicate	that	proper	closure	of	epidermal	abrasion	wounds	and	return	
of	 injured	 skin	 to	 near-	normal	 homeostasis	 require	 both	 rapid	 re-	
epithelialization	and	increase	in	epidermal	signalling.
3.4 | Simulating fibrin clot density and different 
wound geometries predicts their effects on the 
type and thickness of dermal scar
Previous	studies	showed	that	physiological	inflammatory	processes	
are	necessary	to	achieve	normal	full-	thickness	wound	repair,	while	
abnormal	 inflammation	 levels	may	 lead	 to	 pathological	 scarring48. 
Important	components	of	the	inflammation	phase	of	wound	healing	
are	diverse	immune	cell	types49	and	the	formation	of	a	fibrin	clot50. 
Fibrin	clot	is	initiated	by	the	activation	and	aggregation	of	platelets,	
and	 platelets	 release	 α-	granule	 content,	 containing	mitogenic	 and	
chemotactic	growth	factors	important	for	wound	healing51.	Among	
these	platelet-	derived	growth	factors	is	TGFβ120,	which	functions	as	
a	positive	regulator	of	ECM	deposition52.	Therefore,	 in	our	model-
ling,	we	 incorporated	the	effect	of	 immune	cell–derived	and	fibrin	
clot–derived	 putative	 activator	 (modelled	 as	 A)	 on	 healing	 of	 full-	
thickness	dermal	wounds	 (Figure	S4).	We	assumed	 that	 fibrin	 clot	
forms	in	the	wound	bed	region	during	the	transition	between	hemo-
stasis	and	inflammation	phases	(the	starting	point	of	our	simulations)	
and	 that	 it	 can	 have	 high	 density	 or	 be	 defective	 (ie	 low	 density)	
(Figure	S5).	We	also	assumed	 that	 fibrin	 clot	 serves	as	a	 “passive”	
source	for	A	signal	that	diffuses	through	D and E	compartments,	acts	
on	 dermal	 components	 and	 degrades	 over	 time	 (Figure	4L,	 Figure	
S6).	 For	 the	 immune	 cells,	we	 assumed	 that	 they	 serve	 as	 an	 “ac-
tive”	source	for	A,	but	that	they	produce	A	only	when	A	levels	are	
already	above	homeostatic.	Naturally,	this	results	in	transient	activa-
tion	of	immune	cells	near	the	wound	edge	and	fibrin	clot—the	site	of	
elevated	A	(Figures	S7,	S8).
We	ran	a	series	of	simulations,	starting	with	dermal	wounds	that	
are	deep	and	wide	 (Figure	S9A),	 imitating	 large	excisional	wounds,	
and	that	 form	high-	density	 fibrin	clot	 (Figure	4A-	B’’’).	Under	 these	
conditions,	A	in	the	wound	bed	reached	high	level	(Figure	4A’’’),	in-
cluding	from	immune	cells	(Figure	S7A),	triggering	fibroblast	hyper-	
proliferation	 in	 and	 around	 the	 wound	 (Fig	4A’,	 B’,	 J,	 black	 line).	
Fibroblast	overproduction	was	accompanied	by	ECM	overproduction	
(Fig	4A,	B,	I,	black	line),	and	the	resulting	scar	became	prominently	
raised	and	hypertrophic-	like	(Figure	4K,	black	line).	 Importantly,	al-
though	fibrin	clot	decayed	to	zero	only	after	 three	simulated	days	
(Figure	4L,	 black	 line),	 signalling	 effects	 of	 clot-	derived	A	on	ECM	
deposition	and	fibroblast	density	persisted	beyond	that	period.	This	
is	because	expanding	fibroblasts	overtook	as	the	dominant	source	
of	excessive	A	production	(Figure	4B’’’)	and	immune	cells	continued	
to	produce	A	beyond	day	3	(Figure	S7I,	black	line).	Confirming	these	
findings	about	fibrin	clot	was	simulation	of	deep	and	wide	wounds	
with	defective,	low-	density	fibrin	clot	(Figure	S10A,	B’’’).	Under	low-	
density	 clot	 conditions,	 signalling	 levels	 for	A	 and	 I	 in	 and	 around	
wound	bed	remained	relatively	low	(Figure	S10A’’,	A’’’)	and	fibroblast	
density	 decreased	 (Figure	 S10J,	 black	 line),	while	 that	 of	 ECM	 re-
mained	 almost	 unchanged	 (Figure	 S10I,	 black	 line).	 Consequently,	
dermal	thickness	recovery	dynamics	were	slow,	such	that	raised	scar	
did	 not	 develop	 and,	 instead,	 healed	wounds	 acquired	 depressed,	
hypotrophic-	like	appearance.
Next,	we	modelled	the	effects	of	wound	geometries	on	wound	
healing,	comparing	deep	and	wide	wounds	with:	(a)	shallow	and	wide,	
(b)	very	shallow	and	wide,	and	(c)	deep	and	narrow	wounds	(Figure	
S9).	Under	high	fibrin	clot	conditions,	wounds	of	all	sizes	healed	with	
raised	scars	of	varying	degree	 (Figure	4K)	that	had	 increased	ECM	
density	(Figure	4I)	and	increased	fibroblast	density	(Figure	4J).	This	
was	underlined	by	increased	A/I	levels	(Figure	4),	including	increased	
A	from	immune	cells	(Figure	S7),	and	depended	on	initial	high	A	lev-
els	originating	from	high-	density	clot.	At	the	same	time,	prominent	
size-	dependent	differences	were	observed.	Simulations	suggest	that	
the	degree	of	dermal	scarring	strongly	correlates	with	the	wound's	
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depth	 rather	 than	 its	 width.	 Indeed,	 deep	 and	 narrow	 wounds	
(Figure	4G–H’’’)	resulted	in	higher	degree	of	scarring	as	compared	to	
very	shallow	but	wide	wounds	(Figure	4E–F’’’,	K,	green	vs	red	line).
Interestingly,	 the	 above	 correlations	 between	 wound	 size	 and	
scarring	 outcome	were	 altered	 under	 low-	density	 fibrin	 clot	 con-
ditions.	 Wounds	 of	 all	 sizes	 acquired	 depressed,	 hypotrophic-	like	
appearance	 (Figure	S10K),	with	 scars	 resulting	 from	deep	wounds	
showing	decreased	fibroblast	density	(Figure	S10J).	At	the	signalling	
level,	compared	to	high-	density	clot	wounds,	simulated	low-	density	
clot	 wounds	 quickly	 restored	 A/I	 levels	 to	 pre-	wounding	 state	
(Figure	S10).
Lastly,	as	proof	of	principle	of	the	model's	scalability,	we	simu-
lated	healing	of	deep	and	wide	wounds	with	dense	fibrin	clot	with	
the	version	of	the	model	that	contains	two	activators:	A1	that	only	
stimulates	 ECM	production	 and	A2	 that	 only	 stimulates	 fibroblast	
proliferation	 (Figure	S11).	We	 tested	 the	dependency	of	ECM	and	
fibroblasts	on	fibrin	clot–derived	activator	by	assigning	the	clot	 to	
contain	only	A1	 (Figure	S12,	yellow	 lines)	or	A2	 (Figure	S12,	green	
lines).	Simulations	showed	that	 fibroblast	density	highly	depended	
on	its	activator	A2	 (Figure	S12B),	but	that	lack	of	A1	can	be	largely	
compensated	by	A2	 for	ECM	production	 (Figure	S12A).	This	 result	
lays	the	framework	for	modelling	more	complex	wound	healing	sce-
narios	in	the	future.
4  | DISCUSSION
In	this	work,	we	describe	new	hybrid	mathematical	model	designed	
to	 study	 the	 effects	 of	 epidermal-	dermal	 interactions	 on	 the	mo-
lecular	and	cellular	dynamics,	and	outcomes	of	skin	wound	healing.	
Our	simulations	suggest	that	putative	activator	and	inhibitor	signal-
ling	factors	produced	both	in	the	epidermis	and	in	the	dermis	are	im-
portant	for	proper	wound	repair.	If	either	of	these	signalling	sources	
were	perturbed	in	the	model,	dermal	homeostasis	and	repair	became	
altered,	underlined	by	the	defects	in	maintenance	and	restoration	of	
ECM	and	fibroblast	densities.	For	example,	our	model	predicts	how	
different	signalling	regimes	affect	the	degree	of	skin	scarring	in	the	
scenario	when	wound	closure	kinetics	are	perturbed.	In	the	context	
of	epidermal	abrasion	 injuries,	 the	ability	of	basal	keratinocytes	to	
rapidly	increase	the	production	of	A	and	I	over	the	baseline	homeo-
static	levels	was	predicted	to	be	critical	for	preventing	skin	scarring	
in	fast	re-	epithelializing	wounds	and	to	minimize	scarring	in	wounds	
with	defective	re-	epithelialization,	that	simulates	chronic	epidermal	
wounds.
Our	simulations	also	make	several	predictions	regarding	the	ef-
fects	of	geometry	and	fibrin	clot	in	dermal	wounds.	First,	modelling	
results	suggest	that	dermal	wounds	of	all	geometries	heal	by	form-
ing	 scar	 tissue	 that	differs	 in	 its	ECM	and	 fibroblast	 compositions	
compared	to	unwounded	skin.	This	 is	consistent	with	the	available	
experimental	and	clinical	data	that	adult	partial-	thickness	and	full-	
thickness	 wounds	 repair	 by	 scarring53.	 Second,	 wide	 but	 shallow	
simulated	 wounds—an	 equivalent	 of	 superficial	 partial-	thickness	
dermal	wounds—repaired	with	 smaller	 scars	 as	 compared	 to	 deep	
wounds	of	different	width,	an	equivalent	of	deep	partial-	thickness	
and	full-	thickness	dermal	wounds.	Indeed,	this	modelling	prediction	
is	 broadly	 consistent	 with	 the	 available	 experimental	 and	 clinical	
data.	Superficial	dermabrasion	wounds,	even	when	relatively	wide,	
typically	repair	with	no	noticeable	scar54,	while	deep,	full-	thickness	
wounds	 even	 when	 relatively	 narrow,	 such	 as	 full-	thickness	 inci-
sional	surgical	wounds,	repair	with	visible	scars55.	Third,	simulations	
suggest	strong	effects	of	fibrin	clot	on	the	trajectories	and	healing	
outcomes	of	dermal	wounds.	Clot	density	had	the	strongest	effect	
on	 the	 simulated	 repair	 of	 deep	 wounds,	 with	 high-	density	 clots	
causing	 distinctly	 raised,	 hypertrophic-	like	 scars,	 while	 deficient,	
low-	density	 clots	 causing	 somewhat	 depressed,	 hypotrophic-	like	
scars.	The	initial	clot	density	had	progressively	decreasing	influence	
on	the	healing	outcomes	of	shallow	wounds.	 In	our	model,	 the	ef-
fect	of	clot	is	mediated	by	the	amount	of	activator	that	it	releases,	
with	dense	clots	releasing	larger	activator	quantities.	Indeed,	fibrin	
clots	contain	platelet-	derived	growth	factors	and	recent	proteomic	
studies	started	to	define	their	composition56,57.	Our	modelling	pre-
dictions	warrant	new	study	on	the	effect	of	fibrin	clot	in	the	animal	
model	for	wound	healing,	where	clot	formation	can	be	regulated.
From	 the	 mathematical	 perspective,	 our	 model	 provides	 sev-
eral	 advantages.	 Discrete	 nature	 of	 the	 epidermal	 compartment	
enables	 to	 model	 behaviour	 of	 individual	 keratinocytes,	 including	
cell	proliferation,	migration	and	signal	production.	Within	its	current	
framework,	 the	model	 can	be	easily	 adjusted	 to	 incorporate	 addi-
tional	epithelial	 cell	 types,	 such	as	hair	 follicle	and/or	 sweat	gland	
cell	 types.	The	model	accounts	 for	dermal	compartment	dynamics	
using	continuum	description,	which	eliminates	the	need	for	a	sub-
stantially	more	 complex	 and	 computation	 cost-	heavy	 discrete	 de-
scription.	Additional	components,	as	shown	with	immune	cells	and	
two	activator	species,	can	be	relatively	easily	added	into	the	current	
model	of	the	dermal	compartment	without	having	to	fundamentally	
change	it.	Our	model	also	implicitly	considers	the	epidermal	(E) and 
dermal	 compartments	 (D)	 and	 the	Ω	 boundary	 between	 them	 via	
phase	function,	so	that	a	uniform	mesh	can	be	used	for	both	E and 
D.	This	eliminates	the	necessity	of	generating	two	separate	meshes	
for	E and D	 in	order	to	achieve	sharp	compartment	boundary.	This	
approach	can	be	applied	 to	modelling	additional	 sharp	boundaries	
within	the	skin,	such	as	hair	follicle/dermal	boundary.
In	terms	of	its	limitations,	our	model	does	not	consider	potential	
heterogeneity	in	skin	fibroblast	populations,	and	the	possibility	that	
different	 fibroblast	 subtypes	 can	 respond	 differently	 to	 signalling	
cues	 and	 exert	 distinct	 effects	 on	wound	healing.	 Indeed,	 several	
recent	studies	have	identified	distinct	populations	of	mouse	skin	fi-
broblasts	with	distinct	roles	in	ECM	deposition	during	development	
and	wound	 healing10,37,58–61.	 Rinkevich	 et	 al.	 identified	 two	 popu-
lations	of	mouse	skin	fibroblasts:	En1	(Engrailed	homeobox	1)-neg-
ative and En1-positive	 cells.	 The	 former	 are	 abundant	 during	 skin	
development,	and	the	 latter	 increase	 in	numbers	 late	 in	adulthood	
and	predominantly	deposit	collagen	and	remodel	ECM	during	wound	
healing60.	 Developmental	 change	 in	 En1-	positive	 vs	 En1-negative	
fibroblast	 abundance	 affects	 scarring	 outcomes	 in	 skin	 wound-
ing	 experiments59.	 Driskell	 et	al.	 showed	 that	 during	 mouse	 skin	
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development,	two	distinct	fibroblast	types	differentially	contribute	
to	 the	 formation	of	 the	upper	papillary	and	 lower	 reticular	dermal	
layers58.	Moreover,	during	wound	healing,	reticular	fibroblasts	pop-
ulate	the	wound	first,	before	papillary	fibroblasts,	and	they	deposit	
early	ECM.	Shook	et	al.	 showed	 that	unwounded	mouse	skin	con-
tains	three	fibroblast	populations,	that	one	of	them	shares	high	sim-
ilarity	with	En1-	positive	cells,	and	that	their	contributions	to	wound	
healing	are	distinct37.	Using	single-	cell	RNA-	sequencing,	our	group	
showed	that	early	wound	scars	in	mice	contain	as	many	as	twelve	fi-
broblast	clusters	and	that	they	form	at	least	three	distinct	fibroblast	
differentiation	 trajectories10.	 Drawing	 on	 the	 above	 experimental	
evidence	for	fibroblast	heterogeneity,	it	will	be	of	interest	to	incor-
porate	it	into	wound	healing	models.
Indeed,	a	recently	reported	mathematical	model	of	wound	heal-
ing	 that	utilized	Cellular	Potts	model	accounted	 for	 two	 fibroblast	
subtypes—proliferative	and	collagen-	producing	fibroblasts25.	In	the	
model,	the	switch	between	two	fibroblast	types	was	positively	reg-
ulated	by	ECM	and	was	required	to	achieve	dermal	scar	maturation.	
Our	model	herein	accounts	only	for	one	type	of	dermal	fibroblasts,	
and	ECM	production	is	controlled	by	putative	activator	and	inhibitor	
factors	with	ECM	 feedback	onto	both,	 rather	 than	by	 a	 fibroblast	
state	switch.	We	posit	that	signalling	regulations	in	combination	with	
uncoupled	ECM	and	fibroblast	components	within	the	context	of	a	
hybrid	modelling	approach	may	afford	a	more	precise	description	of	
fibroblast	and	ECM	dynamics	and	their	roles	in	wound	healing.
Lastly,	our	current	model	does	not	fully	recapitulate	all	wound	
healing	phases.	Because	 the	model	 lacks	blood	vessel	 and	blood	
flow	 elements,	 it	 does	 not	 reproduce	 the	 hemostasis	 phase.	
Because	it	contains	fibrin	clot	and	immune	cells,	both	of	which	are	
signalling	 sources,	 the	model	 partially	 reproduces	 the	 inflamma-
tion	phase.	Our	model	is	best	suited	for	studying	the	proliferation	
phase	but	 is	not	 fully	optimized	for	simulating	 long-	term	scar	 re-
modelling.	Additional	elements	with	negative	feedback	function	in	
ECM	remodelling	will	be	required	for	the	model	to	enter	new	sta-
ble	steady	state,	which	would	recapitulate	scar	tissue	maturation.
Overall,	our	multiscale	hybrid	model	provides	a	flexible	and	ef-
ficient	 computational	 framework	 to	 investigate	 epidermal-	dermal	
interactions	and	their	effects	on	wound	healing.	By	systematically	
adding	various	biological	processes	or	elements	that	are	critical	to	
wound	healing,	one	may	use	such	modelling	framework	to	delineate	
and	 predict	 novel	 mechanisms	 that	 have	 not	 been	 previously	 ex-
plored	using	experimental	approaches.
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